The increased ArgMet levels found in cancer cells are in line with overexpression of PRMT1 in human melanoma, breast, and prostate cancer (Bedford, 2007; Hamamoto and Nakamura, 2016). The gene discussed is PRMT1; the disease is prostate cancer.